NO990948D0 - Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner - Google Patents

Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner

Info

Publication number
NO990948D0
NO990948D0 NO990948A NO990948A NO990948D0 NO 990948 D0 NO990948 D0 NO 990948D0 NO 990948 A NO990948 A NO 990948A NO 990948 A NO990948 A NO 990948A NO 990948 D0 NO990948 D0 NO 990948D0
Authority
NO
Norway
Prior art keywords
htlv
medication
infections
preparation
treatment
Prior art date
Application number
NO990948A
Other languages
English (en)
Other versions
NO990948L (no
Inventor
Michael R Jirousek
Douglas K Ways
Lawrence E Stramm
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO990948D0 publication Critical patent/NO990948D0/no
Publication of NO990948L publication Critical patent/NO990948L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO990948A 1996-08-30 1999-02-26 Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner NO990948L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2493896P 1996-08-30 1996-08-30
US08/917,517 US5962446A (en) 1996-08-30 1997-08-26 Therapetutic treatment for human T cell lymphotrophic virus type 1 infection
PCT/US1997/015524 WO1998008508A1 (en) 1996-08-30 1997-08-28 Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections

Publications (2)

Publication Number Publication Date
NO990948D0 true NO990948D0 (no) 1999-02-26
NO990948L NO990948L (no) 1999-04-28

Family

ID=26699066

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990948A NO990948L (no) 1996-08-30 1999-02-26 Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner

Country Status (14)

Country Link
US (1) US5962446A (no)
EP (1) EP0830861A1 (no)
JP (1) JP2002514176A (no)
KR (1) KR20000035864A (no)
CN (1) CN1231608A (no)
AU (1) AU4179397A (no)
BR (1) BR9711366A (no)
CA (1) CA2263161A1 (no)
EA (1) EA199900243A1 (no)
IL (1) IL128493A0 (no)
NO (1) NO990948L (no)
PL (1) PL331759A1 (no)
TR (1) TR199900905T2 (no)
WO (1) WO1998008508A1 (no)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK75289A3 (en) * 1988-02-10 1998-05-06 Hoffmann La Roche Substituted pyrroles, their use for producing a drug, and the drug on their base
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
US5063238A (en) * 1989-11-13 1991-11-05 Merrell Dow Pharmaceuticals Inc. Prevention of glycoprotein enveloped virus infectivity by pyridinyloxazole-2-ones
DE4243321A1 (de) * 1992-12-21 1994-06-23 Goedecke Ag Aminosäurederivate von Heterocyclen als PKC-Inhibitoren
EP0657411B1 (en) * 1993-12-07 1999-06-09 Eli Lilly And Company Synthesis of bisindolylmaleimides
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
PL182124B1 (pl) * 1993-12-07 2001-11-30 Lilly Co Eli Nowe zwiazki oraz srodek farmaceutyczny przeznaczony do leczenia powiklan cukrzycowych lub do leczenia nowotworów PL PL PL PL PL PL PL PL
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors

Also Published As

Publication number Publication date
KR20000035864A (ko) 2000-06-26
CN1231608A (zh) 1999-10-13
TR199900905T2 (xx) 1999-07-21
US5962446A (en) 1999-10-05
JP2002514176A (ja) 2002-05-14
PL331759A1 (en) 1999-08-02
EA199900243A1 (ru) 1999-10-28
CA2263161A1 (en) 1998-03-05
BR9711366A (pt) 1999-08-17
NO990948L (no) 1999-04-28
EP0830861A1 (en) 1998-03-25
AU4179397A (en) 1998-03-19
IL128493A0 (en) 2000-01-31
WO1998008508A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
DE69525148D1 (de) Pharmazeutische formulierung
NO981008L (no) Farmas÷ytisk formulering
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
CY2006007I2 (el) Χρηση αναστολεων cgmp-φωσφοδιεστερασης στην αγωγη της ανικανοτητας
FI955782L (fi) Menetelmä kivun käsittelemiseksi 24-tunnin suun kautta annettavia opioidiformulointeja, joilla saadaan lääkkeen plasmatason nopea alkunousu
EE04579B1 (et) Farnesüülproteiintransferaasi inhibiitorite kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on ette nähtud artropaatiate raviks
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
DK0984773T3 (da) Farmaceutisk formulering med omeprazol
EE9800042A (et) Inhalaatorites kasutatav seade
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
NO20016198L (no) Orale farmasöytiske sammensetninger som inneholder taxaner og fremgangsmåter for anvendelse av samme i behandling
NO20005179D0 (no) Medikament behandling
DK0871438T3 (da) Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation
NO984759D0 (no) Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
BR9508339A (pt) Medicamento
EP0617956A3 (en) Piroxicam containing analgesic anti-inflammatory patch.
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
BR9711329A (pt) Utiliza-Æo de inibidores pkc para a fabrica-Æo de medicamento para tratamento da aids
DE59610423D1 (de) Partikulare arzneiform
DE19681529D2 (de) Pharmazeutische Darreichungsform
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
IL128493A0 (en) Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections
NO996117D0 (no) Anordning for tilfoering av medikamenter samt behandling av virale og mikrobielle infeksjoner og taer ingssyndrom

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application